Q Global Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Q Global Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$829K	–	48
2025 Q2	$829K	Hold	10,000	–	–	0.7%	10
2025 Q1	$811K	Buy	+10,000	New	+$894K	0.66%	10
2024 Q4	–	Sell	-170,000	Closed	-$16.5M	–	53
2024 Q3	$16.8M	Sell	170,000 -100,000	-37%	-$9.83M	14.77%	3
2024 Q2	$25M	Sell	270,000 -50,000	-16%	-$4.48M	17.75%	3
2024 Q1	$30.4M	Hold	320,000	–	–	11.51%	5
2023 Q4	$28.6M	Hold	320,000	–	–	21.65%	3
2023 Q3	$23.4M	Hold	320,000	–	–	15.03%	3
2023 Q2	$26.6M	Sell	320,000 -20,000	-6%	-$1.67M	19.19%	2
2023 Q1	$25.9M	Buy	340,000 +91,683	+37%	+$7.61M	18.13%	2
2022 Q4	$20.6M	Buy	248,317 +56,845	+30%	+$4.6M	9.97%	4
2022 Q3	$15.7M	Buy	191,472 +36,279	+23%	+$3.06M	10.82%	4
2022 Q2	$11.5M	Sell	155,193 -194,807	-56%	-$14.6M	8.94%	3
2022 Q1	$31.5M	Buy	+350,000	New	+$32.3M	19.27%	2

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Q Global Advisors's XBI Position: Q3 2025 in Review

Q Global Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 10,000 shares — an estimated $829K sold.

Q Global Advisors first reported a position in XBI in Q1 2022 and held it in 13 quarters. The position peaked at $31.5M in Q1 2022. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Q Global Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Q Global Advisors sold 10,000 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $829K.
Q Global Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 13 quarters.
Q Global Advisors's State Street SPDR S&P Biotech ETF position peaked at $31.5M in Q1 2022.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Q Global Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.